Apo-AII is an elevated biomaker of chronic non-human primate ethanol self-administration

Alcohol and Alcoholism

Volumn 41, Issue 3, 2006, Pages 300-305

  Freeman, Willard M ^a   Gooch, Randy S ^b   Lull, Melinda E ^a   Worst, Travis J ^b   Walker, Stephen J ^b   Xu, Arron S L ^c   Green, Heather ^b   Pierre, Peter J ^b   Grant, Kathleen A ^b   Vrana, Kent E ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c CIPHERGEN BIOSYSTEMS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN A2; BIOLOGICAL MARKER; PLASMA PROTEIN;

ALCOHOL ABSTINENCE; ALCOHOL CONSUMPTION; ANIMAL EXPERIMENT; ARTICLE; CLINICAL STUDY; CONTROLLED STUDY; FEMALE; IMMUNOBLOTTING; MACACA; MALE; NONHUMAN; PRIMATE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PURIFICATION; PROTEOMICS; STATISTICAL SIGNIFICANCE; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; VALIDATION PROCESS;

ALCOHOL DRINKING; ANIMALS; APOLIPOPROTEIN A-I; APOLIPOPROTEIN A-II; BIOLOGICAL MARKERS; BLOOD PROTEINS; BLOTTING, WESTERN; DIET; FEMALE; MACACA FASCICULARIS; MALE; MOLECULAR WEIGHT; PEPTIDE MAPPING; PROTEIN BINDING; SELF ADMINISTRATION;

ANIMALIA; MACACA; MACACA FASCICULARIS; PRIMATES;

EID: 33646180812     PISSN: 07350414     EISSN: 14643502     Source Type: Journal    
DOI: 10.1093/alcalc/agl021     Document Type: Article

References (41)

1. Adam, B. L., Vlahou, A., Semmes, O. J. et al. (2001) Proteomic approaches to biomarker discovery in prostate and bladder cancers. Proteomics 1, 1264-1270.
2. Alte, D., Ludemann, J., Piek, M. et al. (2003) Distribution and dose response of laboratory markers to alcohol consumption in a general population: Results of the study of health in Pomerania (SHIP). Journal of Studies on Alcohol 64, 75-82.
3. Anton, R. F., Lieber, C. and Tabakoff, B. (2002) Carbohydrate-deficient transferrin and gamma-glutamyltransferase for the detection and monitoring of alcohol use: Results from a multisite study. Alcoholism: Clinical and Experimental Research 26, 1215-1222.
4. Branchi, A., Rovellini, A., Tomella, C. et al. (1997) Association of alcohol consumption with HDL subpopulations defined by apolipoprotein A-I and apolipoprotein A-II content. European Journal of Clinical Nutrition 51, 362-365.
5. Camargo, C. A., Williams, P. T., Vranizan, K. M. et al. (1985) The effect of moderate alcohol intake on serum apolipoproteins A-I and A-II. A controlled study. Journal of the American Medical Association 253, 2854-2857.
6. Conigrave, K. M., Degenhardt, L. J., Whitfield, J. B. et al. (2002) CDT, GGT, and AST as markers of alcohol use: The WHO/ISBRA collaborative project. Alcoholism: Clinical and Experimental Research 26, 332-339.
7. Davies, H., Lomas, L. and Austen, B. (1999) Profiling of amyloid beta peptide variants using SELDI Protein Chip arrays. Biotechniques 27, 1258-1261.
8. De Oliveira E Silva, E. R., Foster, D., McGee Harper M. et al. (2000) Alcohol consumption raises HDL cholesterol levels by increasing the transport rate of apolipoproteins A-I and A-II. Circulation 102, 2347-2352.
9. Del Boca, F. K. and Darkes, J. (2003) The validity of self-reports of alcohol consumption: State of the science and challenges for research. Addiction 98 (Suppl. 2), 1-12.
10. Duhamel, G., Nalpas, B., Goldstein, S. et al. (1984) Plasma lipoprotein and apolipoprotein profile in alcoholic patients with and without liver disease: On the relative roles of alcohol and liver injury. Hepatology 4, 577-585.
11. Echan, L. A., Tang, H. Y., Ali-Khan, N. et al. (2005) Depletion of multiple high-abundance proteins improves protein profiling capacities of human serum and plasma. Proteomics 5, 3292-3303.
12. Floyd, D. W., Friedman, D. P., Daunais, J. B. et al. (2004) Long-term ethanol self-administration by cynomolgus macaques alters the pharmacology and expression of GABA(A) receptors expressed in basolateral amygdala. Journal of Pharmacology and Experimental Therapeutics 311, 1071-1079.
13. Fraser, G. E., Anderson, J. T., Foster, N. et al. (1983) The effect of alcohol on serum high density lipoprotein (HDL). A controlled experiment. Atherosclerosis 46, 275-286.
14. Freeman, W. M., Lull, M. E., Guilford, M. T. et al. (2006) Depletion of abundant proteins from non-human primate serum for biomarker studies. Proteomics, in press.
15. Fung, E. T. and Enderwick, C. (2002) ProteinChip clinical proteomics: computational challenges and solutions. Biotechniques, Suppl., 34-1.
16. Gottrand, F., Beghin, L., Duhal, N. et al. (1999) Moderate red wine consumption in healthy volunteers reduced plasma clearance of apolipoprotein AII. European Journal of Clinical Investigation 29, 387-394.
17. Grant, K. A. and Bennett, A. J. (2003) Advances in nonhuman primate alcohol abuse and alcoholism research. Pharmacology & Therapeutics 100, 235-255.
18. Haber, H., Jahn, H., Ehrenreich, H. et al. (2002) Assay of salsolinol in peripheral blood mononuclear cells of alcoholics and healthy subjects by gas chromatography-mass spectrometry. Addiction Biology 7, 403-407.
19. Harasymiw, J. W. and Bean, P. (2001) Identification of heavy drinkers by using the early detection of alcohol consumption score. Alcohol: Clinical and Experimental Research 25, 228-235.
20. Helander, A. (2003) Biological markers in alcoholism. Journal of Neural Transmission 66, 15-32.
21. Javors, M. A. and Johnson, B. A. (2003) Current status of carbohydrate deficient transferrin, total serum sialic acid, sialic acid index of apolipoprotein J and serum beta-hexosaminidase as markers for alcohol consumption. Addiction 98 (Suppl. 2), 45-50.
22. Kasinathan, C., Vrana, K., Beretta, L. et al. (2004) The future of proteomics in the study of alcoholism. Alcoholism: Clinical and Experimental Research 28, 228-232.
23. Lakshman, R., Tsutsumi, M., Ghosh, P. et al. (2001) Alcohol biomarkers: clinical significance and biochemical basis. Alcoholism: Clinical and Experimental Research 25, 67S-70S.
24. Lapham, S. C., C'de, Baca J., McMillan, G. et al. (2004) Accuracy of alcohol diagnosis among DWI offenders referred for screening. Drug & Alcohol Dependence 76, 135-141.
25. Masarei, J. R., Puddey, I. B., Rouse, I. L. et al. (1986) Effects of alcohol consumption on serum lipoprotein-lipid and apolipoprotein concentrations. Results from an intervention study in healthy subjects. Atherosclerosis 60, 79-87.
26. Montalto, N. J. and Bean, P. (2003) Use of contemporary biomarkers in the detection of chronic alcohol use. Medical Science Monitor 9, RA285-RA290.
27. Nomura, F., Tomonaga, T., Sogawa, K. et al. (2004) Identification of novel and downregulated biomarkers for alcoholism by surface enhanced laser desorption/ionization-mass spectrometry. Proteomics 4, 1187-1194.
28. Pappin, D. J. (2003) Peptide mass fingerprinting using MALDI-TOF mass spectrometry. Methods in Molecular Biology 211, 211-219.
29. Phillips, M. (1984) Sweat-patch testing detects inaccurate self-reports of alcohol consumption. Alcoholism: Clinical and Experimental Research 8, 51-53.
30. Robinson, M. K., Myrick, J. E., Henderson, L. O. et al. (1995) Two-dimensional protein electrophoresis and multiple hypothesis testing to detect potential serum protein biomarkers in children with fetal alcohol syndrome. Electrophoresis 16, 1176-1183.
31. Rosman, A. S. and Lieber, C. S. (1994) Diagnostic utility of laboratory tests in alcoholic liver disease. Clinical Chemistry 40, 1641-1651.
32. Segrest, J. P., Harvey, S. C. and Zannis, V. (2000) Detailed molecular model of apolipoprotein A-I on the surface of high-density lipoproteins and its functional implications. Trends in Cardiovascular Medicine 10, 246-252.
33. Senault, C., Betoulle, D., Luc, G. et al. (2000) Beneficial effects of a moderate consumption of red wine on cellular cholesterol efflux in young men. Nutrition, Metabolism and Cardiovascular Diseases 10, 63-69.
34. Sillanaukee, P. (1996) Laboratory markers of alcohol abuse. Alcohol & Alcoholism 31, 613-616.
35. Tang, H. Y., Ali-Khan, N., Echan, L. A. et al. (2005) A novel four-dimensional strategy combining protein and peptide separation methods enables detection of low-abundance proteins in human plasma and serum proteomes. Proteomics 5, 3329-3342.
36. Taskinen, M. R., Nikkila, E. A., Valimaki, M. et al. (1987) Alcohol-induced changes in serum lipoproteins and in their metabolism. American Heart Journal 113, 458-464.
37. Toneatto, T., Sobell, L. C. and Sobell, M. B. (1992) Predictors of alcohol abusers' inconsistent self-reports of their drinking and life events. Alcoholism: Clinical and Experimental Research 16, 542-546.
38. Vivian, J. A., Green, H. L., Young, J. E. et al. (2001) Induction and maintenance of ethanol self-administration in cynomolgus monkeys (Macaca fascicularis): Long-term characterization of sex and individual differences. Alcoholism: Clinical and Experimental Research 25, 1087-1097.
39. Zhang, L., Yu, W., He, T. et al. (2002) Contribution of human alpha-defensin 1, 2, and 3 to the anti-HIV-1 activity of CD8 antiviral factor. Science 298, 995-1000.
40. Zhang, W. and Chait, B. T. (2000) ProFound: An expert system for protein identification using mass spectrometric peptide mapping information. Analytical Chemistry 72, 2482-2489.
41. Zhang, Z., Bast, R. C., Jr, Yu, Y. et al. (2004) Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer. Cancer Research 64, 5882-5890.